Characteristics | Total, n = 115 | Asymptomatic/mild/moderate disease, n = 87 | Severe/critical disease, n = 28 | p-valuea |
---|---|---|---|---|
Age (years) | ||||
Mean (SD) | 9.5 (6.1) | 9.3 (5.9) | 10.1 (6.7) | 0.449 |
Median (IQR) | 10 (4, 15) | 9 (4, 15) | 10.5 (5, 17) | |
Age group, n (%) | ||||
< 1 year old | 14 (12.2) | 8 (57.1) | 6 (42.9) | 0.180 |
1–5 years old | 20 (17.4) | 18 (90.0) | 2 (10) | |
6–12 years old | 34 (29.5) | 26 (76.5) | 8 (23.5) | |
13–18 years old | 47 (40.9) | 35 (74.5) | 12 (25.5) | |
Sex, n (%) | ||||
Female | 42 (36.5) | 35 (83.3) | 7 (16.7) | 0.179 |
Male | 73 (63.5) | 52 (71.2) | 21 (28.8) | |
Reported symptoms, n (%) | ||||
No symptoms | 1 (0.9) | 1 (100.0) | 0 (0.0) | 1.000 |
Fever | 85 (73.9) | 66 (77.7) | 19 (22.3) | 0.460 |
Respiratory | ||||
Cough | 64 (55.7) | 47 (73.4) | 17 (26.6) | 0.663 |
Coryza | 25 (21.7) | 23 (92.0) | 2 (8.0) | 0.035 |
Sore throat | 13 (11.3) | 8 (61.5) | 5 (38.5) | 0.300 |
Difficulty of breathing | 29 (25.2) | 13 (44.8) | 16 (55.2) | < 0.001 |
Gastrointestinal | ||||
Diarrhea | 11 (9.6) | 8 (72.7) | 3 (27.3) | 0.728 |
Loss of appetite | 16 (13.9) | 11 (68.8) | 5 (31.2) | 0.534 |
Vomiting | 22 (19.1) | 18 (81.8) | 4 (18.2) | 0.586 |
Abdominal pain | 12 (10.4) | 10 (83.3) | 2 (16.7) | 0.728 |
Neurologic | ||||
Headache | 11 (9.6) | 10 (90.9) | 1 (9.1) | 0.290 |
Seizures | 4 (3.5) | 3 (75.0) | 1 (25.0) | 1.000 |
Others | ||||
Anosmia | 4 (3.5) | 4 (100.0) | 0 (0.0) | 0.571 |
Ageusia | 6 (5.2) | 5 (83.3) | 1 (16.7) | 1.000 |
Body weakness | 12 (10.4) | 10 (83.3) | 2 (16.7) | 0.728 |
Rashes | 5 (4.3) | 3 (60.0) | 2 (40.0) | 0.594 |
Interval between onset of symptoms and admission (days) | ||||
Mean (SD) | 11 (22.3) | 11.6 (23.0) | 12.2 (20.3) | 0.015 |
Median (IQR) | 5 (3, 8) | 5 (3, 7) | 6.5 (4, 12.5) | |
0–7 days | 83 (72.2) | 68 (81.9) | 15 (18.1) | |
8–14 days | 18 (15.7) | 9 (50.0) | 9 (50.0) | |
> 15 days | 14 (12.2) | 10 (71.4) | 4 (28.6) | |
Duration of hospitalization (days) | ||||
Mean (SD) | 11 (11.4) | 9.6 (7.4) | 18.5 (17.8) | 0.043 |
Median (IQR) | 8 (6, 12) | 8 (5, 11) | 11 (6, 24.5) | |
Co-morbidityb, n (%) | ||||
Tuberculosis, any form | 20 (17.4) | 10 (50.0) | 10 (50.0) | 0.008 |
Dengue | 14 (12.2) | 12 (85.7) | 2 (14.3) | 0.512 |
HIV | 5 (4.3) | 2 (40.0) | 3 (60.0) | 0.092 |
Other illnesses aside from TB, dengue, HIV | 21 (18.3) | 10 (47.6) | 11 (52.4) | 0.003 |
≥ 1 underlying disease | 56 (48.7) | 32 (57.1) | 24 (42.9) | < 0.001 |
COVID-related diagnosis, n (%) | ||||
Pneumonia | 44 (38.3) | 29 (65.9) | 15 (34.1) | 0.074 |
Acute upper respiratory infection | 22 (19.1) | 21 (95.5) | 1 (4.5) | 0.014 |
Acute respiratory distress syndrome | 2 (1.7) | 0 (0.0) | 2 (100.0) | 0.058 |
Acute gastroenteritis | 5 (4.3) | 5 (100.0) | 0 (0.0) | 0.333 |
Multisystem inflammatory syndrome in children (MIS-C) | 2 (1.7) | 0 (0.0) | 2 (100.0) | 0.058 |
Sepsis | 3 (2.6) | 1 (33.3) | 2 (66.7) | 0.146 |
Myocarditis | 1 (0.9) | 1 (100.0) | 0 (0.0) | 1.000 |
Neurologicc | 4 (3.5) | 3 (75.0) | 1 (25.0) | 1.000 |
Vaccination status, n (%) | ||||
Not vaccinated | 113 (98.3) | 85 (75.2) | 28 (24.8) | 1.000 |
Vaccinated | 2 (1.7) | 2 (100.0) | 0 (0.0) | |
Outcome, n (%) | ||||
Died | 10 (8.7) | 2 (20.0) | 8 (80.0) | < 0.001 |
Discharged | 105 (91.3) | 85 (80.9) | 20 (19.1) |